Gan & Lee Pharmaceuticals (603087.SH) has announced that its subsidiary, Gan & Lee Pharmaceuticals Brazil Trading and Pharmaceutical Import Co., Ltd., recently received a Good Manufacturing Practice (GMP) certification issued by the Brazilian Health Regulatory Agency (ANVISA). The successful acquisition of this sterile preparation GMP certification from ANVISA indicates that the company's manufacturing facilities, equipment, and infrastructure comply with Brazilian GMP standards. This achievement lays a solid foundation for the company to further expand its presence in the Brazilian market and other international markets, representing a positive step forward in the implementation of its internationalization strategy.
Comments